CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION

Atrial fibrillation is a common cardiac arrhythmia. Amiodarone is an effective drug used for atrial fibrillation treatment. Various side effects of this drug including amiodarone-induced thyrotoxicosis are discussed. A clinical case is presented to provide data for the differential diagnosis between...

Full description

Bibliographic Details
Main Author:	O. V. Gaisenok
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	atrial fibrillation amiodarone side effects amiodarone-induced thyrotoxicosis
Online Access:	https://www.rpcardio.online/jour/article/view/856

Similar Items

Acute myopathy secondary to amiodarone-induced thyrotoxicosis
by: Dave Duggan, et al.
Published: (2021-12-01)

Thyroidectomy in patients with amiodarone-induced thyrotoxicosis
by: U. A. Tsoy, et al.
Published: (2021-08-01)

Amiodarone-induced thyrotoxicosis: state of the art
by: Elena A. Lebedeva, et al.
Published: (2017-10-01)

Management of Amiodarone-Induced Thyrotoxicosis at a Cardiac Transplantation Centre
by: Michelle Isaacs, et al.
Published: (2018-08-01)

THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS
by: O. V. Gaisenok
Published: (2016-01-01)

Amiodarone-induced thyrotoxicosis type 2: predictors and treatment options
by: A. S. Ermolaeva, et al.
Published: (2019-05-01)

Late-onset thyrotoxicosis after the cessation of amiodarone
by: Melissa E. Middeldorp, et al.
Published: (2020-11-01)

Treatment of amiodarone-induced thyrotoxicosis resistant to conventional therapy
by: Nišić Tanja, et al.
Published: (2017-01-01)

A case report of surgical treatment of amiodarone-induced thyrotoxicosis in a patient with multiple organ failure
by: M. A. Salov, et al.
Published: (2022-09-01)

AMIODARONE THYROTOXICOSIS IN A PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: P. Kh. Dzhanashiya, et al.
Published: (2009-06-01)

Amiodarone-induced thyrotoxicosis in a pediatric patient: A rare and demanding clinical case
by: Sofia Oliveira, et al.
Published: (2019-09-01)

Dysfunction of the thyroid gland during amiodarone therapy: a study of 297 cases
by: Czarnywojtek A, et al.
Published: (2016-04-01)

Unmarked Case of Amiodarone-Induced Thyrotoxicosis
by: N. I. Volkova, et al.
Published: (2011-09-01)

A case of probable Amiodarone-induced pancreatitis in the treatment of atrial fibrillation: a literature review and case report
by: Christopher J. Mercogliano, et al.
Published: (2017-11-01)

Amiodarone induced thyrotoxicosis may not respond to therapeutic plasma exchange like patients with graves disease: A report of two cases and literature review
by: Ismail Yildiz, et al.
Published: (2019-03-01)

The Utility of Intravenous Methylprednisolone as an Adjunct Treatment for Drug-Resistant Amiodarone-Induced Thyrotoxicosis
by: Krzysztof Cezary Lewandowski, et al.
Published: (2024-01-01)

Management of amiodarone-induced thyrotoxicosis
by: C Rajeswaran, et al.
Published: (2003-11-01)

Rise and fall of thyroid radiologic density during the time course of amiodarone-induced thyrotoxicosis
by: Laure Felix, et al.
Published: (2023-01-01)

Predictors of time to conversion of new‐onset atrial fibrillation to sinus rhythm with amiodarone therapy
by: Ihsan Dursun, et al.
Published: (2020-08-01)

Amiodarone-Induced Pulmonary Toxicity in a Patient With Paroxysmal Atrial Fibrillation and Recurrence of Pulmonary Toxicity
by: Nuri Köse, et al.
Published: (2022-01-01)

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
by: Hesham S. Taha, et al.
Published: (2022-05-01)

Amiodarone Induced Thyrotoxicosis and Treatment Complications in a Man With Cyanotic Congenital Heart Disease: A Case Report
by: Marvin Wei Jie Chua, et al.
Published: (2020-10-01)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
by: Abolfath Alizadeh, et al.
Published: (2022-01-01)

Thyroid arterial embolization in a patient with congenital heart disease and refractory amiodarone-induced thyrotoxicosis
by: Bruno Bouça, et al.
Published: (2023-01-01)

Clinical Characteristics of Atrial Flutter and Its Response to Pharmacological Cardioversion with Amiodarone in Comparison to Atrial Fibrillation
by: Maciej T. Wybraniec, et al.
Published: (2023-06-01)

Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
by: Niloofar Dadashpour, et al.
Published: (2015-06-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
by: K. G. Adamyan, et al.
Published: (2015-11-01)

Amiodarone treatment investigation on the correlation between the drug sensitivity for paroxysmal atrial fibrillation and gene polymorphism
by: Shuxin Hou, et al.
Published: (2016-01-01)

A Case of Amiodarone-Induced Thyrotoxicosis : A diagnostic and therapeutic dilemma
by: Sudheer Ahamed PS, et al.
Published: (2009-12-01)

Rhythm and rate control effects of intravenous amiodarone for atrial fibrillation complicated by acutely decompensated heart failure
by: Daisuke Horiuchi, MD, et al.
Published: (2014-06-01)

Prophylactic effect of Amiodarone and in combination with vitamin C in reducing atrial fibrillation after coronary artery bypass
by: Alireza Kamali, et al.
Published: (2021-09-01)

Does prophylactic low-dose amiodarone decrease the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery? A randomized controlled trial
by: Mohamed Ali Ahmed, et al.
Published: (2022-09-01)

DUOX1 Gene Missense Mutation Confers Susceptibility on Type 2 Amiodarone-Induced Thyrotoxicosis
by: Olga Biakina, et al.
Published: (2023-02-01)

Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
by: Li Y, et al.
Published: (2023-12-01)

SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
by: N P Dorofeeva, et al.
Published: (2017-03-01)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
by: Kuan-Cheng Lai, et al.
Published: (2018-05-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
by: Mengran Zhang, et al.
Published: (2021-08-01)

Atrial fibrillation after transhiatal esophagectomy with transcervical endoscopic esophageal mobilization: one institution’s experience
by: Elizabeth M. Colwell, et al.
Published: (2018-06-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
by: D. A. Kuzhel, et al.
Published: (2016-01-01)

Total thyroidectomy in a patient awaiting heart transplant with amiodarone‐induced thyrotoxicosis: A case report
by: Filipa Amador, et al.
Published: (2023-02-01)